Augmentation of cutaneous immune responses by ATPγS: Purinergic agonists define a novel class of immunologic adjuvants

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 7725-7731

  Granstein, Richard D ^a   Ding, Wanhong ^a   Huang, Jing ^a   Holzer, Aton ^a   Gallo, Richard L ^b   Di Nardo, Anna ^b   Wagner, John A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; B7 ANTIGEN; CD86 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PURINE P2X1 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y9 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOMODULATION; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY;

EID: 20444407339     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.7725     Document Type: Article

References (21)

1. Singh, M., and D. T. O'Hagan. 2002. Recent advances in vaccine adjuvants. Pharm Res. 19: 715-728.
2. Hunter, R. L. 2002. Overview of vaccine adjuvants: present and future. Vaccine 20: S7-S12.
3. Alving, C. R. 2002. Design and selection of vaccine adjuvants: animal models and human trials. Vaccine 20: S56-S64.
4. Streuen, J. W., and P. R. Bergstresser. 1984. LC: APC of the epidermis. Immunobiology 186: 285-300.
5. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81.
6. Nestle, F. O., X. G. Zheng, C. B. Thompson, L. A. Turka, and B. J. Nickoloff. 1993. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151: 6535-6545.
7. + Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages. J. Invest. Dermatol. 103: 678-683.
8. Kurimoto, I., M. Arana, and J. W. Streilein. 1994. Role of dermal cells from normal and ultraviolet B-damaged skin in induction of contact hypersensitivity and tolerance. J. Immunol. 152: 3317-3323.
9. Campton, K., W. Ding, Z. Yan, H. Ozawa, K. Seiffert, E. Miranda, A. Lonati, S. Beissert, and R. D. Granstein. 2000. Tumor antigen presentation by dermal antigen-presenting cells. J. Invest. Dermatol. 115: 57-61.
10. Mizumoto, N., T. Kumamoto, S. C. Robson, J. Sevigny, H. Matsue, K. Enjyoji, and A. Takashima, 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8: 358-365.
11. Berchtold, S., A. L. Ogilvie, C. Bogdan, P. Muhl-Zurbes, A. Ogilvie, G. Schuler, and A. Steinkasserer. 1999. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett. 458: 424-428.
12. Ferrari, D., A. La Sala, P. Chiozzi, A. Morelli, S. Falzoni, G. Girolomoni, M. Idzko, S. Dichmann, J. Norgauer, and F. Di Virgilio. 2000. The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J. 14: 2466-2476.
13. Liu, Q. H., H. Bohlen, S. Titzer, O. Christensen, V. Diehl, J. Hescheler, and B. K. Fleischmann. 1999. Expression and a role of functionally coupled P2Y receptors in human dendritic cells. FEBS Lett. 445: 402-408.
14. 7 purinergic receptor: characterization and possible participation in antigen presentation. J. Immunol 163: 1958-1965.
15. Matsue, H., K. Matsue, M. Walters, K. Okumura, H. Yagita, and A. Takashima. 1999. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected "killer" dendritic cells. Nat. Med. 5: 930-937.
16. Ding, W., S. Beissert, L. Deng, E. Miranda, C. Cassetty, K. Seiffert, K. L. Campton, Z. Yan, G. F. Murphy, J. A. Bluestone, et al. 2003. Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis. J. Clin. Invest. 111: 1923-1931.
17. Grabbe, S., S. Bruvers, R. L. Gallo, T. L. Knisely, R. Nazareno, and R. D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146: 3656-3661.
18. Dubyak, G. 2000. Purinergic signaling at immunological synapses. J. Auton. Nerv. Syst: 81: 64-68.
19. Di Virgilio, F., P. Chiozzi, D. Ferrari, S. Falzoni, J. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and R. Baricordi. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97: 587-600.
20. Smith, H. R., D. A. Basketter, and J. P. McFadden. 2002. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin. Exp. Dermatol. 27: 138-146.
21. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.